99¦~07¤ë¸¹ ¹D ªk ªk °T (219)

DEEP & FAR

 

 

¶i¨B©Ê¶·¨Ìªk»{©w

(Federal Circuit 2008-1073) (¤@)

 

 

³¯ºaºÖ ±M§Q¥N²z¤H

¡E¤¤°êÂåÃľǰ|ÃľǨt¾Ç¤h

¡E¤é¥»ºÖ©£¤j¾Ç¥ÍÃľǩҺӤh

¡E¶§©ú¤j¾ÇÂå¾ÇÃIJz©Ò³Õ¤h

 

 

¥H¤U¦Xcordis¤Î±j¥Í¤½¥q(Johnson & Johnson,Inc.)¤½¥qºÙ¬°¡uCordis¡v¡A¦bÃö©ó²Ä6,120,536±M§Q[1] (¤U²¤ºÙ¡¦536±M§Q) ½Ð¨D²Ä8¶µ³Q«I®`¤§³­¼f¹Îµô¨M«á¡A¦V¬ü°êDelaware°Ï¦a¤èªk°|¤W¶D¡A½Ð¨D©Ú­ã¥Hªk«ß°ÝÃD(JMOL)¬°­«¼f¤Î§P¨M¤§Án½Ð¡C¥Ñ©ó¦a¤èªk°|ªk«ß¤W¦³¹H»~ªk«ß¦Ó¥¼¯à»{©w¡¦536±M§Q¤§Åã¦Ó©ö¨£¡A¦]¦¹±À½¨äµô¨M¡C[2]

­I´º

ªi¤h¹y¬ì§Þ²Õ´(Boston Scientific Scimed, Inc.) »PºX¤U¤§ªi¤h¹y¬ì§Þ¦³­­¤½¥q(Boston Scientific Corporation)¦@ºÙ¬°¡uªi¤h¹y¬ì§Þ(Boston Scientific)¡v¾Ö¦³¡z ¡¦536±M§Q¡A¨ä«Y¶îÃÄ«¬¤§¥i¦ùÁY¤ä¬[(drug-eluting expandable stent)¦Óªþ±aµÛµL¦å¤pªOÂHªþªí­±(non-thrombogenic surface)¤§¶î¼h¡Cªi¤h¹y¬ì§Þ©ó2003¦~3¤ë±±¶DCordis¡A¯S§O«ÅºÙCordis¤§CypherTM¤ä¬[¡A«I¥Ç¡¦536±M§Q¤§½Ð¨D²Ä8¶µ¡C°ß¤@¦b±±¶D¤¤¤§²Ä8¶µ«Y¨Ìªþ½Ð¨D¶µ²Ä6¶µ¡A¦Ó²Ä6¶µ«h¨Ìªþ©ó½Ð¨D¶µ²Ä1¶µ¡C½Ð¨D¶µ²Ä1¶µ¡B²Ä6¶µ¡B²Ä8¶µ¤À­z¦p¤U¡G

½Ð¨D¶µ

1.¤@ºØ¦Ü¤Ö¤@³¡¤À¥i´Ó¤J±wªÌÅ餺¤§ÂåÀø¸Ë¸m¡A¨ä¤¤¸Ó¸Ë¸m¦Ü¤Ö¤@³¡¤À«Yª÷ÄÝ¡A¥B¸Óª÷Äݸ˸m³¡¤À¤§¦Ü¤Ö¤@³¡¤À«YÂл\¶î¼h¥HÄÀ¥X¦Ü¤Ö¤@ºØ¥Í²z¬¡©Êª«½è¡A¨ä¤¤¸Ó¶î¼h¥]¬A¨ã¦³µ²¦X©w®ÉÄÀ¥X¬Y¶q¥Í²z¬¡©Êª«½è¤§²¨¤ô¼u©Ê§÷®Æ¤§¤@©³¼h(undercoat)¡A¥B¸Ó¶î¼h§ó¶i¤@¨B¥]¬A¦Ü¤Ö³¡¥÷Âл\¸Ó©³¼h¤§¤@³»¼h(topcoat)¡A¸Ó³»¼h¥]¬A¤@¨ã¥Í²z¦w©w©Ê(biostable)¡A¥i¦bÄÀ¥X¸Ó¥Í²z¬¡©Êª«½è¤§«á©Î´Á¶¡¡Aªø´Á¹ï¸Ó¸Ë¸m³¡¥÷´£¨ÑµL¦å¤pªOÂHªþ¡A¥B¨ä¤¤¸Ó³»¼h«Y¹ê½è¤WµLÃĪ«ÄÀ¥X¡C

 
 
 

  



[1]. June 13, 1996¥Ó½Ð08/663,518¡A©óSeptember 19, 2000¤½§i¡A¨üÅý¤HSchneider (USA) Inc.¡A±M§Q¦WºÙMedical devices with long term non-thrombogenic coatings

[2] See Boston Scientific Scimed, Inc. v. Cordis Corp., No. 03-283-SLR, 2005 U.S. Dist. LEXIS 10735 (D. Del. June 3, 2005) (¡§Claim Construction Opinion¡¨); Boston Scientific Scimed, Inc. v. Cordis Corp., 434 F. Supp. 2d 308 (D. Del. 2006) (¡§Opinion Denying JMOL¡¨); Boston Scientific Scimed, Inc. v. Cordis Corp., Nos. 03-027-SLR, 03-283-SLR, 2007 WL 2775087 (D. Del. Sept. 24, 2007) (¡§Opinion Denying New Trial¡¨).